NIH-funded research NIH-funded research

Investigating the use of corticosteroids for treating a blinding eye infection.

Official title: Parasitic Ulcer Treatment Trial

Funded at University of California, San Francisco · NIH-11074549 · Data updated 2026-11-12

This study is looking at whether corticosteroid eye drops can help people with Acanthamoeba keratitis, a serious eye infection that can cause blindness, by comparing them to a placebo in 200 patients who haven't fully healed after standard treatment.

More Ulcer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 30, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$1,187,979
NIH project number5UG1EY033284-03
Project IDNIH-11074549 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Acanthamoeba keratitis who have not responded adequately to initial anti-amoebic treatment and exhibit ocular inflammation.

Less likely to help

Patients who do not have Acanthamoeba keratitis or those who have already achieved clinical resolution after anti-amoebic therapy may not benefit from this research.

What this research studies

This research focuses on Acanthamoeba keratitis, a severe corneal infection that can lead to blindness and currently has limited treatment options. The trial will involve 200 patients who have shown signs of this infection after receiving standard anti-amoebic therapy. Participants will be randomly assigned to receive either corticosteroid eyedrops or a placebo to determine if corticosteroids can improve healing and visual outcomes. The study aims to assess the effectiveness of this treatment approach over a period of several months.

Why it matters

Potential benefit: If successful, this research could provide a new treatment option that improves recovery and visual outcomes for patients suffering from Acanthamoeba keratitis.

How similar studies have gone: Previous research has shown mixed results regarding the use of corticosteroids in treating Acanthamoeba keratitis, making this trial a critical investigation into a potentially novel treatment approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Keenan, Jeremy David — University of California, San Francisco
  • Study coordinator: Keenan, Jeremy David

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.